Heron Therapeutics Inc is a biotechnology company, developing products to address unmet medical needs. It is developing novel, patient-focused solutions that apply its science and technologies to already-approved pharmacological agents.
| Website: | www.herontx.com |
| Email: | info@herontx.com |
| Main Phone: | +1 650 366-2626 |
| Address: | 123 Saginaw Drive |
| State: | CA |
| City / Town: | Redwood City |
| Country: | USA |
| Postal Code: | 94063 |
| Exchange: | NSC |
| Employees: | 148 |
| NAICS: | Pharmaceutical P |
| Last Price 15.40 | Change $ 0.15 | Change % 0.98 | Tick N/A |
| Bid 14.60 | Bid Size 100.00 | Ask 16.10 | Ask Size 100.00 |
| Open 15.20 | High 15.40 | Low 14.90 | Prev Close 15.25 |
| Last Trade | Volume 363,839 | 52 Wk Hi 21.24 | 52 Wk Low 12.21 |
| Market Cap 833.7 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 54,138,733.00 | EPS (TTM) -4.26 | PE Ratio N/A | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 6 | 23 |
| Number of Buys | 3 | 14 |
| Number of Sells | 3 | 9 |
| Net Activity | 1010991 | 1044835 |
| Last 10 Buys | Shares |
|---|---|
| Kevin C. Tang | 1,000 |
| Kevin C. Tang | 1,000 |
| Kevin C. Tang | 1,000 |
| Kevin C. Tang | 1,000 |
| Kevin C. Tang | 1,000 |
| Barry D. Quart | 1,000 |
| Barry D. Quart | 1,000 |
| Kevin C. Tang | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Robert H. Rosen | 1,000 |
| Robert H. Rosen | 1,000 |
| Robert H. Rosen | 1,000 |
| Robert H. Rosen | 1,000 |
| Robert H. Rosen | 1,000 |
| Robert H. Rosen | 1,000 |
| Robert H. Rosen | 1,000 |
| Robert H. Rosen | 1,000 |
| Kimberly J. Manhard | 1,000 |
| Kimberly J. Manhard | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 55 | 55 | 55 | 55 |
| Low Target Price Estimate | 33 | 38 | 38 | 33 |
| Mean Target Price Estimate | 43.75 | 45.13 | 46 | 43.75 |
| Standard Deviation | 7.01 | 6.03 | 5.32 | 7.01 |
| Date of Most Recent Estimate | 08/11/16 | 08/01/16 | 07/11/16 | 08/19/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-12 |
| SC 13D/A | Amendment to a SC 13D filing | 8 | 2016-08-10 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-08-10 |
| 8-K | Report of unscheduled material events or corporate changes. | 20 | 2016-08-10 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 57 | 2016-08-08 |
| 8-K | Report of unscheduled material events or corporate changes. | 8 | 2016-08-08 |
| 8-K | Report of unscheduled material events or corporate changes. | 45 | 2016-08-01 |
| S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | 30 | 2016-07-29 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-20 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-23 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 8 | 8 | 9 | 9 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
